Improved glucose tolerance via enhanced glucose-dependent insulin secretion in dipeptidyl peptidase IV-deficient fischer rats

Biochemical and Biophysical Research Communications

Volumn 284, Issue 2, 2001, Pages 501-506

  Nagakura, Tadashi ^a   Yasuda, Nobuyuki ^a   Yamazaki, Kazuto ^a   Ikuta, Hironori ^a   Yoshikawa, Seiji ^a   Asano, Osamu ^a   Tanaka, Isao ^a  

^a EISAI CO LTD   (Japan)

Author keywords

Dipeptidyl peptidase IV; Fischer rat strain; Glucagon like peptide 1; Glucose tolerance; Insulin; Mutation

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; PYRROLIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HYPOGLYCEMIA; INSULIN RELEASE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; RAT STRAIN;

EID: 0034811909     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.4999     Document Type: Article

References (31)

1. Glucose-dependency of the insulin stimulatory effect of glucagon-like peptide-1 (7-36) amide on the rat pancreas
2. Enteroglucagon
3. Glucagon-like peptides
4. Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients
5. Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM
6. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum
7. Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV
8. Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo
9. Investigation of glucose-dependent insulinotropic polypeptide-(1-42) and glucagon-like peptide-1-(7-36) degradation in vitro by dipeptidyl peptidase IV using matrix-assisted laser desorption/ionization-time of flight mass spectrometry. A novel kinetic approach
10. Proline-dependent structural and biological properties of peptides and proteins
11. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells
12. Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor
13. Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes
14. Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig
15. Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice
16. Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36amide) concentrations and improves oral glucose tolerance in obese Zucker rats
17. NVP-DPP728 (1-[[[2-[(5-cyanopyridin-2yl)amino]ethyl] amino]acetyl]-2-cyano-(S)-pyrrolidine), a slow-binding inhibitor of dipeptidyl peptidase IV
18. Improved glucose tolerance in rats treated with the dipeptidyl peptidase IV (CD26) inhibitor Ile-thiazolidide
19. Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide
20. Deficiency of membrane-bound dipeptidyl aminopeptidase IV in a certain rat strain
21. 633 → Arg) of dipeptidyl peptidase IV causes its retention and rapid degradation in the endoplasmic reticulum
22. Biosynthesis and degradation of altered immature forms of intestinal dipeptidyl peptidase IV in a rat strain lacking the enzyme
23. GIP biology and fat metabolism
24. Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop
25. The enteroinsular axis in dipeptidyl peptidase IV-negative rats
26. Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26
27. Enzymatic- and renal-dependent catabolism of the intestinotropic hormone glucagon-like peptide-2 in rats
28. Comparative toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in four (sub)strains of adult male rats
29. Strain differences in fear-motivated behavior of rats
30. Glibenclamide-associated hypoglycaemia: A report on 57 cases
31. Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas